Sales and Marketing

Showing 15 posts of 11527 posts found.

J&J continues streamlining by cutting managers

November 11, 2009 Sales and Marketing JJ, restructure

 Johnson & Johnson has announced further restructuring that will see more than 8,000 jobs being cut.The conglomerate says that it …

Pfizer’s new RA treatment shows promise

November 11, 2009 Research and Development, Sales and Marketing Pfizer, RA

 Pfizer has announced data from two clinical studies of its developmental rheumatoid arthritis candidate.CP-690550 is the first in a new …

Vote brings US health reform closer

November 10, 2009 Sales and Marketing Obama, US, US healthcare, reform

Momentus reform of America’s healthcare system is a step closer following the passing of a bill in the House of …

Think tank ranks NHS highly

November 9, 2009 Sales and Marketing NHS

 The Department of Health has taken the opportunity to blow its own trumpet by publicising a US think tank’s report …

Novartis gets German OK for swine flu vaccine

November 5, 2009 Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …

New Merck & Co opens for business

November 5, 2009 Sales and Marketing MA, Merck, restructure

The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009 Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

Phase III success for GSK’s lupus drug

November 3, 2009 Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

GSK-Genmab blood cancer drug approved in US

November 2, 2009 Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …

Jackie Ilacqua, head of oncology, Synovate

November 2, 2009 Sales and Marketing appointment, sales and marketing, synovate

Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009 Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

GSK returns to growth despite US sales hit

October 28, 2009 Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …

GSK begins phase III COPD trials

October 28, 2009 Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
The Gateway to Local Adoption Series

Latest content